Prosecution Insights
Last updated: November 12, 2026
Application No. 19/473,471

SUPPORT SYSTEM FOR TREATMENT DEVICE

Non-Final OA §112§DOUBLEPATENT
Filed
Oct 07, 2025
Priority
Apr 11, 2023 — provisional 63/458,560 +2 more
Examiner
ROANE, AARON F
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Avava Inc.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
83%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
661 granted / 900 resolved
+3.4% vs TC avg
Moderate +10% lift
Without
With
+9.8%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
44 currently pending
Career history
946
Total Applications
across all art units

Office Action

§112 §DOUBLEPATENT
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 20-39 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-18 of U.S. Patent No. 12,336,869. Although the claims at issue are not identical, they are not patentably distinct from each other because they encompass the same essential invention. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 20-39 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 20 recites the limitation "the flexible rod" in lines 3, and 6. There is insufficient antecedent basis for this limitation in the claim. Accordingly, the examiner cannot determine the metes and bounds of the presently claimed invention. Claim 23 recites the limitation "the flexible rod" in line 1. There is insufficient antecedent basis for this limitation in the claim. Accordingly, the examiner cannot determine the metes and bounds of the presently claimed invention. Claim 24 recites the limitation "the flexible rod" in line 1. There is insufficient antecedent basis for this limitation in the claim. Accordingly, the examiner cannot determine the metes and bounds of the presently claimed invention. Claim 25 recites the limitation "the flexible rod" in line 2. There is insufficient antecedent basis for this limitation in the claim. Accordingly, the examiner cannot determine the metes and bounds of the presently claimed invention. Claim 30 recites the limitation "the distal end" in lines 3. There is insufficient antecedent basis for this limitation in the claim. Accordingly, the examiner cannot determine the metes and bounds of the presently claimed invention. Conclusion There is relevant prior art in the form of: 1) de Juan et al. (U.S. Patent Application Publication 2021/0228237), 2) Mark et al. (U.S. Patent Application Publication 2021/0022769), 3) Hulford et al. (U.S. Patent Application Publication 2020/0253678), 4) Sholev (U.S. Patent Application Publication 2008/0091066), and 5) Levy et al. (U.S. Patent 5,346,489). However, this prior art does not anticipate or provide a properly motivated combination making obvious the presently claimed invention as defined by claims 20, and 30 in their entirety. Any inquiry concerning this communication or earlier communications from the examiner should be directed to AARON F ROANE whose telephone number is (571)272-4771. The examiner can normally be reached generally Mon-Fri 8am-9pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at (571) 272-4156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AARON F ROANE/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Oct 07, 2025
Application Filed
Sep 22, 2026
Non-Final Rejection mailed — §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788389
BIOLOGICAL FLUID DRAINAGE DEVICES, SYSTEMS, AND METHODS
3y 10m to grant Granted Nov 10, 2026
Patent 12779245
SYSTEMS, METHODS, AND APPARATUS FOR OCULAR LASER THERAPY
3y 10m to grant Granted Nov 03, 2026
Patent 12758334
METHODS AND APPARATUS FOR SURGICAL TABLE STABILIZATION
2y 3m to grant Granted Oct 13, 2026
Patent 12758105
EAR SYSTEM
2y 1m to grant Granted Oct 13, 2026
Patent 12758359
ANALGESIC DEVICE
1y 0m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
83%
With Interview (+9.8%)
Low
PTA Risk
Based on 900 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month